Savant Capital LLC Has $11.06 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Savant Capital LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 21,866 shares of the healthcare conglomerate’s stock after acquiring an additional 910 shares during the period. Savant Capital LLC’s holdings in UnitedHealth Group were worth $11,062,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the business. DecisionPoint Financial LLC boosted its position in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after acquiring an additional 62 shares in the last quarter. Harbour Trust & Investment Management Co raised its stake in shares of UnitedHealth Group by 4.6% during the fourth quarter. Harbour Trust & Investment Management Co now owns 14,681 shares of the healthcare conglomerate’s stock worth $7,427,000 after buying an additional 643 shares during the last quarter. Liberty Capital Management Inc. grew its holdings in UnitedHealth Group by 0.3% during the fourth quarter. Liberty Capital Management Inc. now owns 14,053 shares of the healthcare conglomerate’s stock valued at $7,109,000 after purchasing an additional 48 shares during the period. LJI Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $232,000. Finally, Howland Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 12.0% in the fourth quarter. Howland Capital Management LLC now owns 1,144 shares of the healthcare conglomerate’s stock valued at $579,000 after buying an additional 123 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $533.17 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market cap of $490.66 billion, a price-to-earnings ratio of 34.40, a P/E/G ratio of 1.45 and a beta of 0.61. The firm’s 50-day simple moving average is $529.18 and its 200 day simple moving average is $564.40. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently commented on UNH shares. Stephens increased their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Truist Financial dropped their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.